Bio-Techne (TECH) closed at $72.78 on November 6, 2026, up 0.2% from the previous close, on volume of 1,933,412 shares (30-day average 2,843,063).
Data as of November 6, 2026.
6-Nov-2026
| # | Date | Strategy | Legs | Contracts |
|---|
Ranked by contracts: multi-leg trades of 200 or more contracts on one day, through Nov 6, 2026. See the 10 largest for 30, 60 and 90 days
Bio-Techne Declares Quarterly Dividend Amid Merck Transaction
TipRanks (Wed, 4-Nov 6:32 AM ET)
Bio-Techne declares $0.08 dividend
Seeking Alpha News (Tue, 3-Nov 10:23 PM ET)
PRNewswire (Tue, 3-Nov 8:30 PM ET)
PRNewswire (Thu, 8-Oct 8:01 AM ET)
Bio-Techne Shareholders Approve Acquisition by Merck KGaA, Darmstadt, Germany
PRNewswire (Wed, 23-Sep 9:20 AM ET)
PRNewswire (Tue, 22-Sep 9:01 AM ET)
Globe Newswire (Fri, 11-Sep 9:38 AM ET)
PRNewswire (Thu, 10-Sep 3:13 PM ET)
Are FULC, WEAV, TECH Obtaining Fair Deals for their Shareholders?
PRNewswire (Wed, 9-Sep 3:24 PM ET)
Globe Newswire (Tue, 8-Sep 10:46 AM ET)
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (about 75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.
Bio-Techne trades on the NASDAQ stock market under the symbol TECH.
As of November 6, 2026, TECH stock price climbed to $72.78 with 1,933,412 million shares trading.
TECH has a beta of 0.49, meaning it tends to be less sensitive to market movements. TECH has a correlation of 0.02 to the broad based SPY ETF.
TECH has a market cap of $11.43 billion. This is considered a Large Cap stock.
Last quarter Bio-Techne reported $321 million in Revenue and $.52 earnings per share. This beat revenue expectation by $6 million and exceeded earnings estimates by $.01.
In the last 3 years, TECH traded as high as $85.57 and as low as $43.20.
The top ETF exchange traded funds that TECH belongs to (by Net Assets): VTI, VOO, VB, RSP, SEQ.
TECH has outperformed the market in the last year with a price return of +25.8% while the SPY ETF gained +10.8%. TECH has also outperformed the stock market ETF in the last 3 month and 2 week periods returning +1.4% and +0.3%, respectively, while the SPY returned -4.1% and -3.2%, respectively.
TECH support price is $72.59 and resistance is $72.74 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that TECH shares will trade within this expected range on the day.
